Zamanian M, Kamran Z, Tavakoli M, Oghenemaro E, Abohassan M, Kubaev A
Mol Neurobiol. 2025; .
PMID: 39890697
DOI: 10.1007/s12035-025-04720-z.
Lai X, Wu J, Kou X, Zhang Y, Shen M, Yu M
Mol Neurobiol. 2024; .
PMID: 39592556
DOI: 10.1007/s12035-024-04625-3.
Escamilla S, Badillos R, Comella J, Sole M, Perez-Otano I, Mut J
Alzheimers Dement. 2024; 20(12):8231-8245.
PMID: 39450669
PMC: 11667538.
DOI: 10.1002/alz.14125.
Stevenson M, Algarzae N, Moussa C
Front Dement. 2024; 3:1458038.
PMID: 39221072
PMC: 11361951.
DOI: 10.3389/frdem.2024.1458038.
Meur S, Karati D
Mol Neurobiol. 2024; 62(1):643-660.
PMID: 38890236
DOI: 10.1007/s12035-024-04286-2.
Src dependency of the regulation of LTP by alternative splicing of exon 5.
Li H, Rajani V, Sengar A, Salter M
Philos Trans R Soc Lond B Biol Sci. 2024; 379(1906):20230236.
PMID: 38853562
PMC: 11343231.
DOI: 10.1098/rstb.2023.0236.
SRC family kinase inhibition rescues molecular and behavioral phenotypes, but not protein interaction network dynamics, in a mouse model of Fragile X syndrome.
Stamenkovic V, Lautz J, Harsh F, Smith S
Mol Psychiatry. 2024; 29(5):1392-1405.
PMID: 38297084
PMC: 11524049.
DOI: 10.1038/s41380-024-02418-7.
DIRECTEUR: transcriptome-based prediction of small molecules that replace transcription factors for direct cell conversion.
Hamano M, Nakamura T, Ito R, Shimada Y, Iwata M, Takeshita J
Bioinformatics. 2024; 40(2).
PMID: 38273708
PMC: 10868337.
DOI: 10.1093/bioinformatics/btae048.
GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases.
Ladagu A, Olopade F, Adejare A, Olopade J
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004401
PMC: 10674917.
DOI: 10.3390/ph16111535.
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.
Gautam D, Naik U, Naik M, Yadav S, Chaurasia R, Dash D
Biomolecules. 2023; 13(11).
PMID: 38002291
PMC: 10669830.
DOI: 10.3390/biom13111609.
Cellular mechanisms of contextual fear memory reconsolidation: Role of hippocampal SFKs, TrkB receptors and GluN2B-containing NMDA receptors.
Nachtigall E, de C Myskiw J, Izquierdo I, Furini C
Psychopharmacology (Berl). 2023; 241(1):61-73.
PMID: 37700085
DOI: 10.1007/s00213-023-06463-y.
Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer's disease.
Li W, Pang Y, Wang Y, Mei F, Guo M, Wei Y
BMC Med. 2023; 21(1):223.
PMID: 37365538
PMC: 10294511.
DOI: 10.1186/s12916-023-02930-7.
Ferulic Acid Improves Synaptic Plasticity and Cognitive Impairments by Alleviating the PP2B/DARPP-32/PP1 Axis-Mediated STEP Increase and Aβ Burden in Alzheimer's Disease.
Mahaman Y, Huang F, Salissou M, Yacouba M, Wang J, Liu R
Neurotherapeutics. 2023; 20(4):1081-1108.
PMID: 37079191
PMC: 10457275.
DOI: 10.1007/s13311-023-01356-6.
Amyloid-β in Alzheimer's disease - front and centre after all?.
Weglinski C, Jeans A
Neuronal Signal. 2023; 7(1):NS20220086.
PMID: 36687366
PMC: 9829960.
DOI: 10.1042/NS20220086.
Apoptosis regulation by the tyrosine-protein kinase CSK.
Fortner A, Chera A, Tanca A, Bucur O
Front Cell Dev Biol. 2022; 10:1078180.
PMID: 36578781
PMC: 9792154.
DOI: 10.3389/fcell.2022.1078180.
Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease?.
Hu Z, Ondrejcak T, Yu P, Zhang Y, Yang Y, Klyubin I
Neural Regen Res. 2022; 18(6):1213-1219.
PMID: 36453396
PMC: 9838152.
DOI: 10.4103/1673-5374.360166.
Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice.
Mahaman Y, Feng J, Huang F, Salissou M, Wang J, Liu R
Nutrients. 2022; 14(20).
PMID: 36296969
PMC: 9609596.
DOI: 10.3390/nu14204284.
Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system.
Eiden L, Hernandez V, Jiang S, Zhang L
Cell Mol Life Sci. 2022; 79(9):492.
PMID: 35997826
PMC: 11072502.
DOI: 10.1007/s00018-022-04451-7.
c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases.
Gutierrez D, Chandia-Cristi A, Yanez M, Zanlungo S, Alvarez A
Neural Regen Res. 2022; 18(2):237-243.
PMID: 35900397
PMC: 9396477.
DOI: 10.4103/1673-5374.346540.
Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology.
Francesca F, Caitlin A, Sarah L, Robyn G
Brain Behav Immun Health. 2022; 21:100435.
PMID: 35252893
PMC: 8892093.
DOI: 10.1016/j.bbih.2022.100435.